Cargando…
Current status and recent advances in reirradiation of glioblastoma
Despite aggressive management consisting of maximal safe surgical resection followed by external beam radiation therapy (60 Gy/30 fractions) with concomitant and adjuvant temozolomide, approximately 90% of WHO grade IV gliomas (glioblastomas, GBM) will recur locally within 2 years. For patients with...
Autores principales: | Minniti, Giuseppe, Niyazi, Maximilian, Alongi, Filippo, Navarria, Piera, Belka, Claus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890828/ https://www.ncbi.nlm.nih.gov/pubmed/33602305 http://dx.doi.org/10.1186/s13014-021-01767-9 |
Ejemplares similares
-
Current status and recent advances in resection cavity irradiation of brain metastases
por: Minniti, Giuseppe, et al.
Publicado: (2021) -
Current status and perspectives of interventional clinical trials for glioblastoma – analysis of ClinicalTrials.gov
por: Cihoric, Nikola, et al.
Publicado: (2017) -
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov
por: Tini, Paolo, et al.
Publicado: (2023) -
Stereotactic Radiosurgery of Multiple Brain Metastases: A Review of Treatment Techniques
por: Bodensohn, Raphael, et al.
Publicado: (2023) -
The evolving role of reirradiation in the management of recurrent brain tumors
por: De Pietro, Raffaella, et al.
Publicado: (2023)